|
|
|
|
|
|
|
Calithera Biosci Com (CALA)
|
|
6.1 -0.35 (-5.43%)
|
04-20 16:00
|
|
Open:
|
6.45
|
Pre. Close:
|
6.45
|
|
High:
|
6.5
|
Low:
|
6.1
|
|
Volume:
|
432,381
|
Market Cap:
|
219M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
6.515 - 6.547
|
6.547 - 6.573
|
|
Low:
|
6.015 - 6.057
|
6.057 - 6.091
|
|
Close:
|
6.042 - 6.105
|
6.105 - 6.156
|
|
|
|
Technical analysis (as of: 2018-04-20 4:28:06 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 7.91 One year: 8.94
|
|
Support:
|
Support1: 5.35 Support2: 4.45
|
|
Resistance:
|
Resistance1:
6.77 Resistance2: 7.65
|
|
Pivot:
|
6.03
|
|
Moving Averages:
|
MA(5): 6.25 MA(20): 6.23
MA(100): 7.84 MA(250): 12.17
|
|
MACD:
|
MACD(12,26):
-0.27  Signal(12,26,9): -0.36
|
|
%K %D:
|
%K(14,3): 42.86 %D(3): 43.92
|
|
RSI:
|
RSI(14): 43.69
|
|
52-Week:
|
High: 20.05
Low: 5.35 Change(%): -45.0
|
|
Average Vol(K):
|
3-Month: 62621
10-Days 60201
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.CALA has closed below upper band by 43.4%. Bollinger Bands are 50.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to CALA's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-04-20T08:00:00-04:00
3 Things In Biotech, April 19: Let's Talk Genito-Urinary Cancer
2018-04-18T09:15:48-04:00
Premarket Gainers as of 9:05 am (04/18/2018)
2018-04-18T07:16:45-04:00
Calithera's CB-839 Fast Track'd for advanced kidney cancer
2018-04-03T17:36:52-04:00
After Hours Gainers / Losers (04/03/2018)
2018-03-29T11:45:44-04:00
Calithera Biosciences: Financial Inefficiency Makes The Company Less Competitive
2018-03-08T22:18:07-05:00
Calithera Biosciences' (CALA) CEO Susan Molineaux on Q4 2017 Results - Earnings Call Transcript
2018-03-08T16:08:32-05:00
Calithera Biosciences misses by $0.09, beats on revenue
2018-03-07T17:35:33-05:00
Notable earnings after Thursday's close
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
